AUPH Latest Press Releases

-- March 30, 2026 --

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Business Wire 8:00 AM

-- March 23, 2026 --

MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition Business Wire 11:00 AM

Aurinia Announces Management Transition Business Wire 8:00 AM

-- February 26, 2026 --

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress Business Wire 6:00 AM

-- February 19, 2026 --

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 Business Wire 6:00 AM

-- November 4, 2025 --

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress Business Wire 6:00 AM

-- November 3, 2025 --

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 Business Wire 6:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software